Antiviral effect of multipurpose contact lens disinfecting solutions against coronavirus.


Journal

Contact lens & anterior eye : the journal of the British Contact Lens Association
ISSN: 1476-5411
Titre abrégé: Cont Lens Anterior Eye
Pays: England
ID NLM: 9712714

Informations de publication

Date de publication:
10 2022
Historique:
received: 15 06 2021
revised: 14 08 2021
accepted: 23 08 2021
pubmed: 2 9 2021
medline: 28 9 2022
entrez: 1 9 2021
Statut: ppublish

Résumé

To evaluate the antiviral potential of five multipurpose disinfecting solutions against coronavirus (mouse hepatitis virus, a surrogate for SARS-CoV-2 human corona virus). Test solutions (Biotrue, renu Advanced [Bausch and Lomb], ACUVUE RevitaLens [Johnson and Johnson Vision], cleadew [Ophtecs corp.] or AOSept Plus [Alcon]) were mixed with the coronavirus mouse hepatitis virus at 10 The three multipurpose disinfecting solutions Biotrue (containing PHMB and polyquaternium-1), renu Advanced (PHMB, polyquaternium-1 and alexidine) and ACUVUE RevitaLens (polyquaternium-1 and alexidine) did not kill the coronavirus at the manufacturers recommended disinfection time in the stand alone test. After treatment, the virus's titer (3.8 ± 0.2 log This study shows that oxidative contact lens disinfecting solutions (i.e. those containing povidone-iodine or hydrogen peroxide) provide superior antiviral activity against a coronavirus surrogate of SARS-CoV-2, unless the full regimen test (rub, rinse, disinfect) is used.

Identifiants

pubmed: 34465537
pii: S1367-0484(21)00147-8
doi: 10.1016/j.clae.2021.101513
pmc: PMC8390374
pii:
doi:

Substances chimiques

Antiviral Agents 0
Biguanides 0
Contact Lens Solutions 0
Disinfectants 0
Phosphates 0
Povidone-Iodine 85H0HZU99M
Hydrogen Peroxide BBX060AN9V
alexidine GVN71CAL3G

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

101513

Informations de copyright

Copyright © 2021 British Contact Lens Association. Published by Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors MY and AKV declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. One author, MW, is a member of the Scientific Advisory Board of Ophtecs corp. whose cleadew disinfectant was tested in this study.

Auteurs

Muhammad Yasir (M)

School of Optometry and Vision Science, University of New South Wales, NSW 2052, Australia.

Ajay Kumar Vijay (A)

School of Optometry and Vision Science, University of New South Wales, NSW 2052, Australia.

Mark Willcox (M)

School of Optometry and Vision Science, University of New South Wales, NSW 2052, Australia. Electronic address: m.willcox@unsw.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH